ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million.

December 9, 2005

Knowing Tumor Cell Structure Improves Treatment Decisions

March 27, 2009

Childhood Cancer Foundation Names New President

September 20, 2002

Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards

September 1, 1989

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995